Synlogic Gestione

Gestione criteri di controllo 2/4

Synlogic Il CEO è Tony Awad, nominato in Mar2024, e ha un mandato di meno di un anno. la retribuzione annua totale è $ 701.53K, composta da 60.3% di stipendio e 39.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.29% delle azioni della società, per un valore di $ 47.74K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 1 anni e 8 anni.

Informazioni chiave

Tony Awad

Amministratore delegato

US$701.5k

Compenso totale

Percentuale dello stipendio del CEO	60.3%
Mandato del CEO	less than a year
Proprietà del CEO	0.3%
Durata media del management	less than a year
Durata media del Consiglio di amministrazione	8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Tony Awad rispetto agli utili di Synlogic?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	-US$37m
Jun 30 2024	n/a	n/a	-US$49m
Mar 31 2024	n/a	n/a	-US$73m
Dec 31 2023	US$702k	US$423k	-US$57m
Sep 30 2023	n/a	n/a	-US$59m
Jun 30 2023	n/a	n/a	-US$65m
Mar 31 2023	n/a	n/a	-US$66m
Dec 31 2022	US$876k	US$411k	-US$66m
Sep 30 2022	n/a	n/a	-US$65m
Jun 30 2022	n/a	n/a	-US$63m
Mar 31 2022	n/a	n/a	-US$61m
Dec 31 2021	US$811k	US$391k	-US$61m
Sep 30 2021	n/a	n/a	-US$60m
Jun 30 2021	n/a	n/a	-US$57m
Mar 31 2021	n/a	n/a	-US$58m
Dec 31 2020	US$723k	US$359k	-US$59m
Sep 30 2020	n/a	n/a	-US$57m
Jun 30 2020	n/a	n/a	-US$57m
Mar 31 2020	n/a	n/a	-US$54m
Dec 31 2019	US$809k	US$325k	-US$51m

Compensazione vs Mercato: La retribuzione totale di Tony ($USD 701.53K ) è superiore alla media delle aziende di dimensioni simili nel mercato UK ($USD 358.67K ).

Compensazione vs guadagni: La retribuzione di Tony è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Tony Awad (44 yo)

less than a year

Mandato

US$701,534

Compensazione

Mr. Antoine Awad, also known as Tony, served as Chief Operating Officer at Synlogic, Inc. since July 2020 and was its Head of Technical Operations since December 12, 2018 until 2020 and serves as Principal...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Antoine Awad	Principal Executive Officer	less than a year	US$701.53k	0.29% $ 47.7k
Timothy Lu	Co-Founder & Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
James Collins	Co-Founder & Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Mary Dooley	VP, Head of Finance and Principal Financial Officer & Principal Accounting Officer	less than a year	Nessun dato	0.13% $ 21.4k
Ajay Munshi	Vice President of Corporate Development	no data	Nessun dato	Nessun dato
Neal Sondheimer	VP & Head of Clinical	1.4yrs	Nessun dato	Nessun dato
Jose-Carlos Gutierrez-Ramos	Advisor	no data	US$1.39m	Nessun dato

1.0yrs

Durata media

44yo

Età media

Gestione esperta: Il team dirigenziale di 0A8U non è considerato esperto (durata media 1 anni), il che suggerisce un nuovo team.

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Timothy Lu	Co-Founder & Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
James Collins	Co-Founder & Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Richard Shea	Independent Director	7.3yrs	US$65.70k	0.0043% $ 704.2
Peter Barrett	Independent Chairman of the Board	10.3yrs	US$92.20k	0.18% $ 29.2k
Edward Mathers	Independent Director	12.1yrs	US$55.70k	0% $ 0
Michael Heffernan	Independent Director	3.9yrs	US$66.20k	0% $ 0
Nick Leschly	Independent Director	8.7yrs	US$55.70k	0.013% $ 2.2k
Paul Miller	Member Scientific Advisory Board	no data	US$956.81k	Nessun dato
Kristala Lanett Prather	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Cammie Lesser	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
Christopher Voigt	Member of Scientific Advisory Board	no data	Nessun dato	Nessun dato
James Flynn	Independent Director	less than a year	Nessun dato	Nessun dato

8.0yrs

Durata media

60yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 0A8U sono considerati esperti (durata media dell'incarico 8 anni).

Synlogic Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Synlogic, Inc., Annual General Meeting, Dec 04, 2024

Synlogic, Inc. Announces Departure of Aoife Brennan as Chief Executive Officer

Synlogic, Inc. Appoints Chief Financial Officer Changes, Effective December 1, 2023

Synlogic, Inc. Appoints Dave Hava as Head of Research and Development

Synlogic, Inc. Announces Appointment of Brendan St. Amant as Corporate Secretary, Effective July 1, 2022

Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer

Recent updates

Third quarter 2024 earnings released: US$0.01 loss per share (vs US$2.57 loss in 3Q 2023)

Synlogic, Inc., Annual General Meeting, Dec 04, 2024

New major risk - Share price stability

New major risk - Financial position

Second quarter 2024 earnings released: EPS: US$0.17 (vs US$3.21 loss in 2Q 2023)

New major risk - Financial position

First quarter 2024 earnings released: US$2.60 loss per share (vs US$3.39 loss in 1Q 2023)

Cable Car Capital Discloses its Views on Synlogic

Synlogic, Inc. Announces Departure of Aoife Brennan as Chief Executive Officer

Synlogic, Inc. Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Synlogic, Inc. Appoints Chief Financial Officer Changes, Effective December 1, 2023

Third quarter 2023 earnings released: US$2.57 loss per share (vs US$3.73 loss in 3Q 2022)

Synlogic, Inc. Announces Implementation of Reduction in Workforce

Synlogic, Inc. Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria

Synlogic, Inc. Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria

Synlogic, Inc. Appoints Dave Hava as Head of Research and Development

Synlogic Receives Non-Compliance Notice From Nasdaq

Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update

Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU) SYNB1934 Advances to Phase 3

Synlogic, Inc Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks

Synlogic, Inc. to Report Q2, 2022 Results on Aug 11, 2022

Synlogic, Inc. Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria

Synlogic, Inc. Announces Appointment of Brendan St. Amant as Corporate Secretary, Effective July 1, 2022

Synlogic, Inc. to Report Q1, 2022 Results on May 12, 2022

Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs At the Society for Inherited Metabolic Disorders 43Rd Annual Meeting

Synlogic Announces Appointment of Michael Jensen as Chief Financial Officer

High number of new directors

Synlogic Presents Data on SYNB8802 for Enteric Hyperoxaluria at American Urological Association (AUA) Annual Meeting

High number of new directors

Synlogic Announces Initiation of Phase 1 Study of SYNB1934 for treatment of Phenylketonuria

Synlogic, Inc. Presents Additional Preclinical Data on Therapeutic Candidates SYNB1934 for Phenylketonuria (PKU) and SYNB8802 for Enteric Hyperoxaluria at Synthetic Biology: Engineering, Evolution & Design (SEED) Conference

Independent Director Chau Khuong has left the company

Synlogic, Inc. Provides Update on its Clinical and Preclinical Programs

Analisi delle retribuzioni degli amministratori delegati

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media